Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    HIV Prevention and Alcohol (R61/R33 Clinical Trials Optional)

    Forecasted

    NIH funds milestone-driven research to develop, pilot, and expand testing of HIV prevention interventions, including approaches addressing alcohol use and related comorbidities.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Intervention and Services Research Trials

    This grant supports pilot studies to develop and test interventions or services for substance use and HIV prevention, requiring collaboration with stakeholders and a clear theory of change.

    HHS-NIH11Due Jul 16, 2029$450,000

    High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)

    This grant supports innovative research at the HIV and substance use intersection, focusing on new avenues for prevention, treatment, and cure among people who use drugs.

    HHS-NIH11Due Feb 3, 2027$9,000,000

    High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)

    This grant aims to support innovative research on the intersection of HIV and substance use, with the goal of advancing prevention, treatment, and cure efforts among people who use drugs. It is open to both individuals and research teams, covering a wide range of research areas.

    HHS-NIH11Due Feb 5, 2027$7,500,000

    Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)

    NIH plans a milestone-driven award supporting planning and early to definitive clinical trials across biomedical and other interventions for up to 7 years; applications are not yet being accepted.

    HHS-NIH11Forecasted Jul 31, 2027Forecasted

    Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)

    Research grant for studying biological, behavioral, and social factors impacting HIV pathogenesis within NIDDK's mission and NIH priorities.

    HHS-NIH11Due Feb 16, 2027$275,000